iRadimed Corporation (IRMD)

iRadimed Corporation (IRMD $76.42)
- $76.42 P/E (TTM): 48.34X Cap: $998M
- View IRMD Profile
- View Questions on IRMD

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

iRadimed Corporation (IRMD $76.42)
- $76.42 P/E (TTM): 48.34X Cap: $998M
- View IRMD Profile
- View Questions on IRMD

Q: Let me be the first to ask you about this company.

Main product appears to be a monopoly with no competition. They are releasing an updated version soon, with a good chunk of their installed base nearing EOL and due for replacement.

Founder led. No debt, net cash. High returns on capital, growing nicely. Secular tale winds in healthcare space. Valuation doesn't seem stretched.

Outside of being smaller in size, any red flags for you? On first glance, is it something you'd personally consider investing in?

Thanks.

Read Answer Asked by Adam on August 21, 2024